Cargando…
T Cell-Mediated Autoimmunity in Glaucoma Neurodegeneration
Glaucoma as the leading neurodegenerative disease leads to blindness in 3.6 million people aged 50 years and older worldwide. For many decades, glaucoma therapy has primarily focused on controlling intraocular pressure (IOP) and sound evidence supports its role in delaying the progress of retinal ga...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716691/ https://www.ncbi.nlm.nih.gov/pubmed/34975917 http://dx.doi.org/10.3389/fimmu.2021.803485 |